Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia

BACKGROUND AND OBJECTIVES: Entecavir is a nucleoside analog used in the treatment of chronic hepatitis B. The efficacy of ETV has not been studied in the Saudi population. The objective of the study was to find undetectable HBV DNA after 48 weeks completion of ETV treatment in real-life versus clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ashqar, Hamad Ibrahim, Al-Quaiz, Mohammed, Dahab, Saleim Towfeig, Peedikayil, Musthafa Chalikandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078629/
https://www.ncbi.nlm.nih.gov/pubmed/23951584
http://dx.doi.org/10.5144/0256-4947.2013.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078629/
https://www.ncbi.nlm.nih.gov/pubmed/23951584
http://dx.doi.org/10.5144/0256-4947.2013.119

Ejemplares similares